HomeNewsBusinessStocksStocks in news: Sun Pharma, Hindalco, Coal India, Tech Mahindra

Stocks in news: Sun Pharma, Hindalco, Coal India, Tech Mahindra

Sun Pharma | Tata Motors | M&M | Hindalco Industries | Coal India | Tech Mahindra | Sun TV Network | Religare Enterprises | Suzlon Energy | Maruti Suzuki and Diamond Power are stocks, which are in the news today.

May 30, 2016 / 09:25 IST
Story continues below Advertisement

Here are stocks that are in news today:

Results today: Tata Motors, M&M, NTPC, Sun Pharmaceutical, Aurobindo, Bata India, GMR Infrastructure, Suzlon Energy, Reliance Communications, Sintex Industries, Godfrey Phillips, Dhanlaxmi Bank, Hitachi Home, Jain Irrigation, GSFC, ITDC, Berger Paints, IPCA Laboratories, Prestige Estates, Insecticides (India), MTNL, Transport Corporation of India, Andhra Bank, Infibeam Incorporation, IVRCL, Fiem Industries, Bajaj Hindusthan Sugar, BGR Energy, Den Networks, Dredging Corporation of India, Kohinoor Foods, KSK Energy Ventures, Liberty Shoes, Lovable Lingerie,  Emco, Financial Tech, Jagran Prakashan, Marksans Pharma, OM Metals Infraprojects, Monsanto India, PC Jeweller, Prime Focus, Rolta India, Sakthi Sugars, Shakti Pumps (India), Sunteck Realty, Amtek Auto, Atul Auto, Gokaldas Exports, Bajaj Electricals, Blue Star, JBM Auto, Jindal Photo, D-Link (India), Donear Industries, Gokaldas Exports, ABG Shipyard, Hindustan Copper, Jindal Poly Films, Kopran, Lloyd Electric & Engineering, Nitco, OM Metals Infraprojects, KNR Constructions, Oriental Carbon & Chemicals, Power Mech Projects, Rajesh Exports, Sathavahana Ispat, Shilpi Cable, Suprajit Engineering, Andhra Sugars, TTK Healthcare, Vivimed Labs, Aegis Logistics, Bhushan Steel, Butterfly Gandhimathi Appliances, Cigniti Technologies, Harrisons  Malayala, IL&FS Engineering and Construction , OnMobile Global, Opto Circuits

Story continues below Advertisement

Sun Pharma-Receives a subpoena from Justice Dept's anti trust division in US on product pricing-Enquiry is for Sun and not Taro where most price increases have taken place-Analysts say unlikely to have any adverse material impact on operations or numbers-Allergan, Par and Endo Pharma made same disclosures in 2015

Coal India-Board approves revision of coal prices by approximately 6.29 percent over current price-Revision of coal prices to be applicable on all subsidiaries-To earn additional revenue of Rs 3,234 crore from price revision for balance year of FY17-Approves differentiated price for non-regulated sector